Aggiudicatario
Exeltis Germany GmbH
Ismaning · DEU
Aggiudicazioni
34
Importo totale aggiudicato
2,3 Mln €
29 aggiudicazione/i congiunta/e conteggiata/e pro quota
Stazioni appaltanti
5
Settori
1
USt-IdNr. DE270418798
Contratti di questo aggiudicatario in scadenza
- —
18 apr 2027
stimata - —
18 apr 2027
stimata 31 dic 2027
dichiarata075 | Desogestrel Filmtabletten [2]46.392 €IKK classicExeltis Germany GmbH, Gedeon Richter Plc. vertreten durch Gedeon Richter Pharma GmbH
- 185.739 €
31 dic 2027
dichiarata 31 dic 2027
dichiarata083 | Dienogest Tabletten u.w. [3]147.023 €IKK classicExeltis Germany GmbH, Gedeon Richter Plc. vertreten durch Gedeon Richter Pharma GmbH, Hormosan Pharma GmbH
- 1.642.475 €
31 dic 2027
dichiarata 31 mar 2028
dichiarataEtonogestrel und Ethinylestradiol - TK, hkk, HEK (ATC-Code: G02BB01)—Techniker KrankenkasseExeltis Germany GmbH, Hormosan Pharma GmbH
31 mar 2028
dichiarataDesogestrel FTA - TK, hkk, HEK (ATC-Code: G03AC09)—Techniker KrankenkasseExeltis Germany GmbH, Gedeon Richter GmbH, Hormosan Pharma GmbH
31 mar 2028
dichiarataDesogestrel FTA - Barmer (ATC-Code: G03AC09)—Techniker KrankenkasseExeltis Germany GmbH, Gedeon Richter GmbH, Hormosan Pharma GmbH
31 mar 2028
dichiarataDesogestrel FTA - DAK-G, KKH (ATC-Code: G03AC09)—Techniker KrankenkasseExeltis Germany GmbH, Gedeon Richter GmbH, Hormosan Pharma GmbH
31 mar 2028
dichiarataDesogestrel FTA - TK, hkk, HEK (ATC-Code: G03AC09)—Techniker KrankenkasseExeltis Germany GmbH, Gedeon Richter GmbH, Hormosan Pharma GmbH
31 mar 2028
dichiarataDesogestrel FTA - Barmer (ATC-Code: G03AC09)—Techniker KrankenkasseExeltis Germany GmbH, Gedeon Richter GmbH, Hormosan Pharma GmbH
31 mar 2028
dichiarataDesogestrel FTA - DAK-G, KKH (ATC-Code: G03AC09)—Techniker KrankenkasseExeltis Germany GmbH, Gedeon Richter GmbH, Hormosan Pharma GmbH
30 set 2028
dichiarataEtonogestrel + Ethinylestradiol - BARMER—BARMER Beschaffung und VergabeAristo Pharma GmbH, Exeltis Germany GmbH
30 set 2028
dichiarataEtonogestrel + Ethinylestradiol - DAK-G, KKH—BARMER Beschaffung und VergabeAristo Pharma GmbH, Exeltis Germany GmbH
- —
30 set 2028
dichiarata - —
30 set 2028
dichiarata - 323.662 €
31 dic 2028
dichiarata - 141.550 €
31 dic 2028
dichiarata - 323.662 €
31 dic 2028
dichiarata - 141.550 €
31 dic 2028
dichiarata - 10 €RV
31 dic 2028
dichiarata - 10 €RV
31 dic 2028
dichiarata 31 dic 2028
dichiarataChlormadinon + Ethinylestradiol (FTA)—GWQ ServicePlus AGExeltis Germany GmbH, HEXAL AG, PUREN Pharma GmbH & Co. KG
31 dic 2028
dichiarataLevonorgestrel + Ethinylestradiol (FTA)—GWQ ServicePlus AGExeltis Germany GmbH, Hormosan Pharma GmbH, ratiopharm GmbH
Tutti i contratti in scadenza →